Cohort Company News - MedTech Innovator

Promaxo Raises $4.17M in Funding Round Led by Huami Corporation

DateJan 13 2021

. Promaxo’s patient-centric approach will provide patients with cutting-edge technology as it works to expand the frontiers of knowledge in the fields of medical imaging, robotics, and artificial intelligence.

Itamar Medical acquires Spry Health to improve remote sleep apnea treatment

DateJan 13 2021

Leading Israeli sleep apnea digital health company Itamar Medical has announced its acquisition of Spry Health in a bid to expand its product offerings into remote monitoring and support for the condition.

Novus Diagnostics gets €2.4M grant for rapid sepsis test

DateJan 12 2021

Irish company Novus Diagnostics has been awarded €2.4 million in funding to commercialise its rapid sepsis test. The only Irish company to be awarded funding from this round of the European Innovation Council (EIC) Accelerator pilot, DCU-based Novus Diagnostics has been working in collaboration with two Dublin hospitals on validating the SepTec diagnostic device.

NEUROFLOW closes $20M Series B Investment

DateJan 12 2021

NeuroFlow, the market leader in solutions supporting technology-enabled behavioral health integration, announces today the initial closing of a $20M Series B financing round led by Magellan Health (NASDAQ: MGLN), in addition to a syndicate including previous investors.

Rhaeos: Greater Insight for Hydrocephalus Solutions

DateJan 07 2021

The shunts that relieve fluid pressure in the brain are failure-prone, but current imaging methods don’t provide enough data to assess their function. Rhaeos is seeking to fill that gap with a wearable flow monitor that yields insightful data in minutes.

CathWorks Announces $30M in New Financing

DateJan 07 2021

CathWorks reported the completion of a $30 million Series D financing round. Proceeds from the financing will be used to expand commercialization of the company's FFRangio system.

Avisi closed an oversubscribed Seed round

DateJan 05 2021

These funds will be instrumental in advancing #VisiPlate to clinical trials, growing our team, and taking us one step closer to helping tens of millions of patients preserve their vision.

How artificial intelligence and augmented reality are changing medical proctoring during COVID-19 (featuring ExplORer Surgical)

DateJan 04 2021

Launched out of the University of Chicago Department of Surgery in 2013, ExplORer recently added augmented reality technology that acts as a virtual laser pointer for medical device specialists to provide on-screen guidance for surgeons similarly to how sports announcers use a Telestrator to mark up plays.

Vancouver-based Stoko creates products for ‘athletes of all abilities’

DateJan 04 2021

Formerly known as Embrace Orthopaedics, the Vancouver-based brand Stoko merges “functional support and activewear” for athletes. For the company, that means creating a Health Canada-registered knee support in innovative athletic tights.

Mitochondrial Transplantation to Treat Ischemia-Reperfusion Injury: Interview with Dr. Alexander Schueller, CEO of cellvie

DateDec 22 2020

cellvie, a company based in Houston, Texas, is developing a mitochondrial transplantation therapy to help reduce the damage caused by ischemia-reperfusion injury.

Strados Labs receives FDA 510(k) clearance for its wireless lung sound measurement platform, RESP™

DateDec 22 2020

Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing lung sounds remotely across healthcare settings.

Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology

DateDec 21 2020

Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology.

€7.4 Million in blended funding awarded to SepTec to develop and scale ground-breaking innovation

DateDec 21 2020

SepTec Ltd is proud to announce that we were one of the 38 companies chosen as Europe’s most promising start-ups and SMEs by the European Innovation Council and was awarded €7.4 Million in blended funding to develop and scale up our ground-breaking innovation.

Avenda Health Receives FDA Clearance for their Focal Laser Ablation System

DateDec 16 2020

Avenda Health's image-guided focal laser ablation system is designed to ablate soft tissue in a physician's office. It uses a proprietary laser needle and thermal optical sensor to precisely target and treat soft tissue while minimizing the impact on healthy tissues.

Centerline Biomedical Kicks Off First Clinical Study of Intra-Operative Positioning System Technology

DateDec 15 2020

Centerline Biomedical, Inc. (Centerline) announced Tuesday the completion of the first surgical case in its MOTION clinical study of its innovative Intra-Operative Positioning System (IOPS™) surgical navigation platform.

FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

DateDec 15 2020

CardioFlux®, the most advanced commercially available magnetocardiograph (MCG), leverages highly sensitive room temperature magnetometers to deliver noninvasive measurement of the heart’s naturally-generated magnetic fields.

Osteoporosis Prevention Product Wins FDA Breakthrough Device Designation (featuring Bone Health Technologies)

DateDec 15 2020

Bone Health Technologies, creator of the OsteoBoost Vibration Belt that promises to reduce the risk of osteoporosis, has been granted “Breakthrough Device” designation by the US Food & Drug Administration. The FDA awards Breakthrough Device designation to products “that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions.”

Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

DateDec 14 2020

Avelas Biosciences, Inc., pioneering the field of intraoperative fluorescent cancer imaging, today announced that the company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during breast cancer surgery.

U.K. Invests $330M to Lead the World In Healthcare AI (featuring Kheiron Medical Technologies)

DateDec 10 2020

This first tranche of investment boasts companies at a range of stages, from minimum viable products to established companies ready to scale.

Smart Stethoscope Helps Monitor and Diagnose Respiratory Conditions: Interview with Helena Binetskaya, CEO of Healthy Networks

DateDec 09 2020

LungPass, an AI-powered Bluetooth stethoscope has been developed by Healthy Networks, a company based in Talinn, Estonia. The device can analyze sounds from the lungs and help to diagnose or monitor a variety of respiratory conditions, with an initial focus on pneumonia and COPD.